Because of the multifactorial origin of dementia (Alzheimer–vascular spectrum dementia), future studies are required to consider associated environmental and genetic factors, as well as biomarkers (i.e., APOE-ε4) and other covariates (i.e., chronic stress) that may increase the risk of dementia in patients who consume PPIs. This evidence concerns the gene APOE and dementia.